What is the accepted number of lifetime treatments of Accutane (isotretinoin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Number of Lifetime Isotretinoin Treatments for Acne

There is no specific limit to the number of lifetime isotretinoin treatments that can be administered for acne, but multiple courses may be necessary for certain patient populations, particularly younger patients and those with severe, recalcitrant acne. 1, 2

Factors Affecting Need for Multiple Courses

Age-Related Considerations

  • Younger patients (under 16 years) have significantly higher relapse rates:
    • Nearly 80% of patients under 16 years treated with standard dosing (120-150 mg/kg) required a second course within 2 years 1
    • Patients under 12 years: 14 of 20 (70%) relapsed within 1 year 3
    • Patients 12-14 years: 21 of 47 (45%) relapsed within 1 year 3
    • Patients 14-16 years: 23 of 66 (35%) relapsed within 1 year 3

Dosing and Relapse Risk

  • Cumulative dose is critical in determining relapse rates:
    • Standard cumulative dose: 120-150 mg/kg 2, 4
    • Patients receiving <120 mg/kg have significantly higher relapse rates 4
    • Higher cumulative doses (>220 mg/kg) are associated with lower relapse rates (26.6% vs 43.8% at 1 year) 1
    • High-dose regimens (cumulative dose ~290 mg/kg) have shown even lower relapse rates (12.5% over 3 years) 5

Timing of Relapse

  • Most relapses occur within the first 3 years after treatment completion:
    • 96% of relapses occur within 3 years of stopping therapy 4
    • Continuing treatment for at least 2 months after achieving clearance may decrease relapse frequency 1

Special Patient Populations Requiring Multiple Courses

  • Patients with specific acne types may need multiple courses:
    • Linear lesions with undermining tracks of follicular epithelium
    • Patients with history of "sinus track" disease (pilonidal sinus, hidradenitis)
    • Women with adrenal or ovarian syndrome with elevated androgens 3

Safety of Multiple Courses

  • No evidence suggests that multiple courses of isotretinoin at standard dosing pose additional safety risks beyond those of a single course
  • A 16-20 week course at recommended doses has no clinically significant effect on bone mineral density in adolescents (12-17 years) 6
  • Long-term follow-up (up to 10 years) has not revealed significant long-term systemic or biochemical side effects 4

Monitoring During Repeated Courses

For each course of isotretinoin, the same monitoring protocol should be followed:

  • Pregnancy testing for women of childbearing potential (mandatory) 2
  • Laboratory monitoring every 2-3 months:
    • Lipid panel
    • Liver function tests 2
    • Blood glucose levels in diabetic patients 2
  • Contraception must be maintained during treatment and for 3 years after discontinuation in women of childbearing potential 1

Conclusion

While there is no absolute limit to the number of isotretinoin courses a patient can receive in their lifetime, the need for repeated courses should prompt consideration of higher cumulative dosing (>220 mg/kg) during each course to reduce relapse rates. Younger patients should be counseled about the likelihood of requiring multiple courses due to their higher relapse rates.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acne Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral isotretinoin. How can we treat difficult acne patients?

Dermatology (Basel, Switzerland), 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.